3Dinwoodie W R, Bartolucci A A, Lyman G H, et al. Phase Ⅱ evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trim [J]. Cancer Treat Rep, 1986,70 (2) : 267 -270.
4Kelsen D, Hilaris B, Coonley C, et al. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma [J]. Am J Med, 1983,75(4):645-652.
5De Besi P, Salvagno L, Endrizzi L, et al. Cisplatin, bleomycin and methotrexate in the treatment of advanced oesophageal cancer [J]. Eur J Cancer Clin Oncol, 1984,20 (6) : 743 -747.
6Kelsen D P, Fein R, Coonley C, et al. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer [J]. Cancer Treat Rep, 1986,70(2) :255-259.
7Vogl S E, Greenwald E, Kaplan B H. Effective chemotherapy for esophageal cancer with methotrexate, bleomycin, and cisdiamminedichloroplatinum Ⅱ[J]. Cancer, 1981,48(12): 2555-2558.
8Bleiberg H, Convoy T, Paillot B, et al. Randomised phase Ⅱ study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer [J]. Eur J Cancer, 1997,33 (8) : 1216-1220.
9Conroy T, Etienne P L, Adenis A, et al. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival [J]. Ann Oncol, 2002,13(5) :721-729.
10Polee M B, Kok T C, Siersema P D, et al. Phase Ⅱ study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus [J].Anticancer Drugs, 2001,12(6) :513-517.
2Steinbach G, Hong WK. Early detection of esophageal cancer by chromoendoscopy[J].Cancer, 1995,76(6) : 919-921.
3Brodmerkel GJ Jr. Schillerls test: an aid in esophagoscopic diagnosis[J].Gastroenterology, 1971,60 : 813.
4Moschler O, Spahn TW, Middelberg-Bisping C, et al. Chromoendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer[J]. Digestion, 2006,73 (2-3) : 160-166.
